Akili Interactive Labs

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Akili Interactive Labs sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials none currently recruiting 10 completed top decile by trial count

Akili Interactive Labs: 13 sponsored US clinical trials, none currently recruiting.

Akili Interactive Labs sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. The most-studied condition in this pipeline is Attention Deficit Hyperactivity Disorder, with 3 trials.

Top-decile sponsor footprint

Akili Interactive Labs ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

13 total, page 1 of 1

ACTIVE NOT RECRUITING NA

EndeavorOTC® Research Study in College Students

NCT06376032
ACTIVE NOT RECRUITING

EndeavorOTC™ Prospective Product Registry

NCT06109051
ACTIVE NOT RECRUITING

EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

NCT05991167
COMPLETED NA

Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)

NCT05183919
COMPLETED NA

Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

NCT04897074
COMPLETED NA

Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01

NCT03844269
COMPLETED NA

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

NCT03649074
COMPLETED NA

Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)

NCT03310281
COMPLETED NA

Software Treatment for Actively Reducing Severity of ADHD - Follow Up

NCT02828644
COMPLETED NA

Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents

NCT02822937
COMPLETED NA

Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements

NCT02792296
COMPLETED NA

Software Treatment for Actively Reducing Severity of ADHD

NCT02674633
COMPLETED NA

Cognitive ADHD Videogame Exploratory Study

NCT01943539

Therapeutic Areas

Attention Deficit Hyperactivity Disorder 3
Attention Deficit Disorder With Hyperactivity 2
ADHD 2
University Students 1
Attention 1
Cognition 1

How the Akili Interactive Labs archive is shaped

13 indexed studies, none listed as recruiting (0% open); 10 completed (77%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Attention Deficit Hyperactivity Disorder (3 trials), 5 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Akili Interactive Labs: archived-pipeline peers nationwide

Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Akili Interactive Labs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%2%4%6%8%10% Total trials Recruiting share Akili Interactive LabsAdaptimmuneAgennixAlumisAndrei Iagaru10xBio22nd Century Group23andMe3-C Institute for Social Development
Akili Interactive Labs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Akili Interactive Labs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Akili Interactive Labs page

13 registered trials is a research-attention snapshot, not an endorsement of Akili Interactive Labs or any single study.

  • None of Akili Interactive Labs's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Attention Deficit Hyperactivity Disorder is the condition Akili Interactive Labs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Attention Deficit Hyperactivity Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Akili Interactive Labs pipeline card: 13 registered trials from official public datasets.Report a data error.